Updated Jul 16, 2026 · Last SEC filing 2026-07-01
BioAge Labs, Inc. (BIOA) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 2 Form 8-K material event filings were reported by BIOA in the last 90 days. 2 Form 144 notices of proposed sale were filed for BIOA stock. InsiderAlpha tracks every BIOA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001709941 |
|---|
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-01 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Barton Shane | Principal Accounting Officer | M — Option exercise | 4.3K | $10.85 | $47K | SEC | |
| Barton Shane | Principal Accounting Officer | M — Option exercise | 4.1K | $4.30 | $17K | SEC | |
| Barton Shane | Principal Accounting Officer | M — Option exercise | 4.0K | $8.39 | $34K | SEC | |
| Barton Shane | Principal Accounting Officer | M — Option exercise | 7.9K | $4.38 | $34K | SEC | |
| Barton Shane | Principal Accounting Officer | S — Open-market sale | 20.2K | $25.19 | $509K | SEC | |
| Barton Shane | Principal Accounting Officer | M — Option exercise | 9.3K | $10.85 | $101K | SEC | |
| Barton Shane | Principal Accounting Officer | S — Open-market sale | 42.4K | $25.21 | $1.07M | SEC | |
| Barton Shane | Principal Accounting Officer | M — Option exercise | 14.2K | $4.38 | $62K | SEC | |
| Barton Shane | Principal Accounting Officer | M — Option exercise | 9.0K | $4.30 | $39K | SEC | |
| Barton Shane | Principal Accounting Officer | M — Option exercise | 7.3K | $8.39 | $61K | SEC | |
| GOLDSTEIN DOV A MD | Chief Financial Officer | M — Option exercise | 3.5K | $4.38 | $16K | SEC | |
| RUBIN PAUL D | Chief Medical Officer | M — Option exercise [10b5-1] | 5.4K | $4.11 | $22K | SEC | |
| RUBIN PAUL D | Chief Medical Officer | M — Option exercise [10b5-1] | 3.4K | $6.57 | $22K | SEC | |
| RUBIN PAUL D | Chief Medical Officer | S — Open-market sale [10b5-1] | 8.8K | $17.81 | $157K | SEC | |
| RUBIN PAUL D | Chief Medical Officer | M — Option exercise [10b5-1] | 2.0K | $6.57 | $13K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for BioAge Labs, Inc. (BIOA). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Barton Shane | 18 | $1.97M |
| GOLDSTEIN DOV A MD | 2 | $16K |
| Hemrajani Rekha | 1 | — |
| ENRIGHT PATRICK G | 1 | — |
| Pande Vijay Satyanand | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BIOA insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live BIOA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.